Recent advances in deep learning enabled the development of AI systems that outperform humans in many tasks and have started to empower scientists and physicians with new tools. In this Comment, we discuss how recent applications of AI to aging research are leading to the emergence of the field of longevity medicine.
References
Cutler, R. G. & Mattson, M. P. Ageing Res. Rev. 5, 221–238 (2006).
de Grey, A. D. N. J. SELT https://doi.org/10.2202/1941-6008.1011 (2007).
Kaneshiro, B., Geling, O., Gellert, K. & Millar, L. Hawaii Med. J. 70, 168–171 (2011).
Yadav, D., Singh, R., Vatsa, M. & Noore, A. PLoS ONE 9, e112234 (2014).
Esteva, A. et al. Nat. Med. 25, 24–29 (2019).
Mnih, V. et al. Nature 518, 529–533 (2015).
Hinkson, I. V., Madej, B. & Stahlberg, E. A. Front. Pharmacol. 11, 770 (2020).
Zhavoronkov, A. & Mamoshina, P. Trends Pharmacol. Sci. 40, 546–549 (2019).
Mamoshina, P. et al. Sci. Rep. 9, 142 (2019).
Hou, Y.-C. C. et al. Proc. Natl Acad. Sci. USA 117, 3053–3062 (2020).
Moore, J. H. & Raghavachari, N., Workshop Speakers. Front. Artif. Intell. 2, 12 (2019).
Zhavoronkov, A., Li, R., Ma, C. & Mamoshina, P. Aging 11, 10771–10780 (2019).
Author information
Authors and Affiliations
Contributions
K.F.L. and A.Z. both contributed to the design and implementation of the research and to the writing of the manuscript. E.B. contributed to the rewriting and editing of the manuscript and supported the initial design.
Corresponding author
Ethics declarations
Competing interests
K.F.L. is the founder of Sinovation Ventures, a commercial venture fund investing in AI with commercial interests in a broad range of AI companies and projects relating to longevity medicine. A.Z. is the founder and shareholder of Insilico Medicine, a drug discovery company with a focus on aging and age-related diseases, and Deep Longevity, a commercial company specializing in biomarker development and DACs. E.B. is an independent advisor to Insilico Medicine.
Rights and permissions
About this article
Cite this article
Zhavoronkov, A., Bischof, E. & Lee, KF. Artificial intelligence in longevity medicine. Nat Aging 1, 5–7 (2021). https://doi.org/10.1038/s43587-020-00020-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43587-020-00020-4
- Springer Nature America, Inc.
This article is cited by
-
Evaluating Longevity as a Farm Animal Welfare Indicator
Food Ethics (2024)
-
Privacy and surveillance concerns in machine learning fall prediction models: implications for geriatric care and the internet of medical things
AI & SOCIETY (2023)
-
Aging and automation in economies with search frictions
Journal of Population Economics (2022)
-
Achieving a three-dimensional longevity dividend
Nature Aging (2021)